NEW YORK (GenomeWeb News) – RayBiotech today announced a deal with Norwegian organizations for the use of RayBiotech's antibody arrays for sample analysis services.
The deal, which involves Oslo University Hospital and the University of Oslo, provides for the use of RayBiotech's array technology for the high-throughput detection and analysis of protein biomarkers in biological samples. Potential biomarkers include cytokines, growth factors, and other secreted factors related to complex diseases, such as cancer.
The service program will be aimed at academic and industrial clients and will be applicable to human specimens, as well as animal models, such as mice, pigs, rats, and primates, RayBiotech said.
"It is our expectation that these antibody array testing services will help researchers to identify new molecular and biochemical pathways and promote drug discovery as well as drug target validation," Rani Huang, president, COO, and co-founder of Norcross, Ga.-based RayBiotech, said in a statement.
Financial and other terms of the deal were not disclosed.